iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · IEX Real-Time Price · USD
25.36
+1.66 (7.00%)
At close: Aug 12, 2022 4:00 PM
25.44
+0.08 (0.32%)
After-hours:
Aug 12, 2022 7:56 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Revenue
|
344.78 | 0 | 0 | 0 |
| Gross Profit
|
344.78 | 0 | 0 | 0 |
| Selling, General & Admin
|
40.51 | 15.34 | 8.84 | 4.31 |
| Research & Development
|
59.37 | 29.9 | 19.21 | 17.19 |
| Operating Expenses
|
99.87 | 45.24 | 28.05 | 21.5 |
| Operating Income
|
244.9 | -45.24 | -28.05 | -21.5 |
| Interest Expense / Income
|
0 | 0 | 0 | 0.07 |
| Other Expense / Income
|
-11.56 | -7.15 | -5.71 | -3.52 |
| Pretax Income
|
256.46 | -38.09 | -22.34 | -18.05 |
| Income Tax
|
41.94 | -0.06 | 0.12 | 0.01 |
| Net Income
|
214.52 | -38.03 | -22.45 | -18.06 |
| Preferred Dividends
|
0 | 5.37 | 4.08 | 2.01 |
| Net Income Common
|
214.52 | -43.4 | -26.54 | -20.07 |
| Shares Outstanding (Basic)
|
35 | 15 | 0 | 1 |
| Shares Outstanding (Diluted)
|
38 | 15 | 0 | 1 |
| Shares Change
|
150.49% | 7336.28% | -67.03% | - |
| EPS (Basic)
|
6.10 | -2.88 | -130.85 | -32.63 |
| EPS (Diluted)
|
5.68 | -2.88 | -130.85 | -32.63 |
| Free Cash Flow Per Share
|
14.55 | -1.69 | -117.69 | -31.42 |
| Gross Margin
|
100.00% | - | - | - |
| Operating Margin
|
71.00% | - | - | - |
| Profit Margin
|
62.20% | - | - | - |
| Free Cash Flow Margin
|
148.50% | - | - | - |
| Effective Tax Rate
|
16.35% | 0.15% | -0.53% | -0.06% |
| EBITDA
|
257.07 | -37.56 | -21.72 | -17.48 |
| EBITDA Margin
|
74.60% | - | - | - |
| Depreciation & Amortization
|
0.6 | 0.54 | 0.61 | 0.51 |
| EBIT
|
256.46 | -38.09 | -22.34 | -17.98 |
| EBIT Margin
|
74.40% | - | - | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).